SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-24-008117
Filing Date
2024-03-01
Accepted
2024-03-01 08:09:57
Documents
5
Effectiveness Date
2024-03-01
Reference 429
333-270400

Document Format Files

Seq Description Document Type Size
1 S-8 prime-2024sx8.htm S-8 54956
2 EX-FILING FEES prime-2024sx8xex107filingf.htm EX-FILING FEES 17863
3 EX-5.1 prime-2024sx8xex51opinion.htm EX-5.1 7577
4 EX-23.1 prime-2024sx8xex231consent.htm EX-23.1 2119
5 logoa.jpg GRAPHIC 14883
  Complete submission text file 0001628280-24-008117.txt   98786
Mailing Address 21 ERIE ST. CAMBRIDGE MA 02139
Business Address 21 ERIE ST. CAMBRIDGE MA 02139 617-465-0013
Prime Medicine, Inc. (Filer) CIK: 0001894562 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277567 | Film No.: 24707045
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)